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Background
In recent years a large amount of literature data empha-
sizes the interrelationship between pathogenic mechan-
isms of chronic hepatitis C virus (HCV) infection and lipid
and glucid metabolism. In this study we aimed to charac-
terize lipid and glucidic metabolic patterns in chronically
HCV-infected patients and to evaluate the role of HCV on
cardiovascular risk (CVR).
Methods
We conducted a cross-sectional analysis on chronic HCV-
infected adult patients, monitored at the National Institute
of Infectious Diseases “Prof. Dr. Matei Balş”. Patients with
diabetes mellitus, chronic alcohol consumption, other
chronic liver diseases, HBV or HIV co-infections were
excluded. We recorded demographic data, HCV infection
history, personal and family history of CVR factors. We
measured height and weight for body mass index, waist to
hip ratio, blood pressure and we assessed the 10 years
CVR using Framingham score. Blood samples were tested
for lipid profile, serum glucose, glycosylated hemoglobin
(HbA1c), liver enzymes, and viral load (VL). Liver histology
was assessed by Fibromax (Biopredictive).
Results
Seventy-six patients with a median age of 51years (IQR
44.25-58.0) were included. Sex ratio was F:M=1.53. Med-
ian VL was 118500 IU/mL (IQR 0-600951). Twenty-five
percent (19/76) of the patients had no fibrosis (F0), 51.3%
(39/76) had hepatitis (F1-2), 6.5% (5/76) had a fibrosis
score equivalent to transition to cirrhosis (F3), and 17.1%
(13/76) had cirrhosis (F4). Mean serum cholesterol, LDL
and triglycerides were 187 mg/dL (IQR 166-220), 119 mg/
dL (IQR 93-147) and respectively 94 mg/dL (IQR 69.25-
132.0). Patients with no fibrosis were more frequently
younger and females (p=0.000, respectively 0.015), had
higher cholesterol (p=0.014) and LDL levels (p=0.009) and
lower VL (p=0.017) and CVR according to Framingham
score (p=0.000). Patients with cirrhosis were more fre-
quently males (p=0.033), and had higher viral load
(p=0.011) and serum glucose (p=0.027). Fibrosis score cor-
related to age (p=0.000), VL (p=0.001), higher CVR
(p=0.001), low LDL (p=0.034), high glucose (p=0.031).
The VL correlated to HDL (p=0.023) and with lower
HbA1c levels (p=0.022).
Conclusions
In patients with chronic HCV infection although high
fibrosis correlates to better lipid profiles, it also corre-
lates to higher cardiovascular risk.
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